Zhongfan Zhang

China Japan Union Hospital Of Jilin University
Changchun, 130033, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Extracorporeal membrane oxygenation-supported one-stop surgery for transcatheter aortic valve replacement and percutaneous coronary intervention in high-risk complex coronary artery and aortic valvular disease: a case report.

Extracorporeal membrane oxygenation-supported one-stop surgery for transcatheter aortic valve replacement and percutaneous coronary intervention in high-risk complex coronary artery and aortic valvular disease: a case report.

Journal: Frontiers in cardiovascular medicine

Published: April 01, 2025

A New Nomogram Prediction Model for Left Ventricular Thrombus in Patients with Left Ventricular Aneurysm after Acute Myocardial Infarction.

A New Nomogram Prediction Model for Left Ventricular Thrombus in Patients with Left Ventricular Aneurysm after Acute Myocardial Infarction.

Journal: Reviews in cardiovascular medicine

Published: March 27, 2024

Silencing of UTX Mitigates Aging-Associated Cardiac Fibrosis via Blocking Cardiac Fibroblasts-to-Myofibroblasts Trans-Differentiation.

Silencing of UTX Mitigates Aging-Associated Cardiac Fibrosis via Blocking Cardiac Fibroblasts-to-Myofibroblasts Trans-Differentiation.

Journal: Anatolian journal of cardiology

Published: June 08, 2023

Clinical profile and prognosis of elderly patients with left ventricular thrombus after anticoagulation.

Clinical profile and prognosis of elderly patients with left ventricular thrombus after anticoagulation.

Journal: Thrombosis journal

Published: April 24, 2023

Rivaroxaban, a direct inhibitor of coagulation factor Xa, attenuates adverse cardiac remodeling in rats by regulating the PAR-2 and TGF-β1 signaling pathways.

Rivaroxaban, a direct inhibitor of coagulation factor Xa, attenuates adverse cardiac remodeling in rats by regulating the PAR-2 and TGF-β1 signaling pathways.

Journal: PeerJ

Published: March 14, 2023

Rivaroxaban in heart failure patients with left ventricular thrombus: A retrospective study.

Rivaroxaban in heart failure patients with left ventricular thrombus: A retrospective study.

Journal: Frontiers in pharmacology

Published: July 31, 2022

Prognosis and New Predictors of Early Left-Ventricular Thrombus Following ST-Elevation Myocardial Infarction.

Prognosis and New Predictors of Early Left-Ventricular Thrombus Following ST-Elevation Myocardial Infarction.

Journal: International journal of general medicine

Published: October 08, 2021

Prophylactic Rivaroxaban Therapy for Left Ventricular Thrombus After Anterior ST-Segment Elevation Myocardial Infarction.

Prophylactic Rivaroxaban Therapy for Left Ventricular Thrombus After Anterior ST-Segment Elevation Myocardial Infarction.

Journal: JACC. Cardiovascular interventions

Published: October 07, 2021

Loeffler endocarditis with intracardiac thrombus: case report and literature review.

Loeffler endocarditis with intracardiac thrombus: case report and literature review.

Journal: BMC cardiovascular disorders

Published: October 07, 2021

Rivaroxaban versus Vitamin K Antagonists (warfarin) based on the triple therapy for left ventricular thrombus after ST-Elevation myocardial infarction.

Rivaroxaban versus Vitamin K Antagonists (warfarin) based on the triple therapy for left ventricular thrombus after ST-Elevation myocardial infarction.

Journal: Heart and vessels

Published: June 05, 2021

Value of the platelet-to-lymphocyte ratio in the prediction of left ventricular thrombus in anterior ST-elevation myocardial infarction with left ventricular dysfunction.

Value of the platelet-to-lymphocyte ratio in the prediction of left ventricular thrombus in anterior ST-elevation myocardial infarction with left ventricular dysfunction.

Journal: BMC cardiovascular disorders

Published: June 14, 2020

Showing 1-11 of 11

Last Updated: 09/26/2026